October 2026

Fielding all incoming help requests from clients via telephone and/or emails in a courteous manner. Document all pertinent end user identification information, including name, department, contact information and nature of problem or issue

Preferred certifications include pharmacovigilance or drug safety training from recognized industry bodies such as DIA or similar professional organizations.

Bachelors Degree in Science with Chemistry or B.SC.(Pharmacy) of any University in India established or incorporated by or under a Central Act, a Provincial Act or a State Act or the institutions recognised by the University Grants Commission or an equivalent Qualification.

Maintain safety tracking systems and ensure timely completion of assigned activities and deliverables. Conduct MedDRA coding, drug coding, and maintenance of drug dictionaries as required.

Responsible for Regulatory Affairs activities in India and neighbouring markets, encompassing product registrations, regulatory submissions, approvals, renewals, lifecycle management, regulatory intelligence, and liaison with Health Authorities.

The Lead is expected to have extensive experience and provide thought leadership in Data Governance and Compliance, as well as on how the regulatory and pharmacovigilance (safety) systems, processes, and data interact and interface with other aspects of the Astellas information ecosystem.

To strengthen India’s clinical research capabilities and expand the country’s participation in global clinical trials, National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, and AstraZeneca India have partnered to extend clinical trial capabilities beyond the metros, building a trained workforce and inspection-ready sites in 25 emerging research geographies across India.

Biocon Limited has entered into a global patent settlement and licence agreement with Genentech, a member of the Roche Group, resolving pending disputes over Pebrilzo® (bPertuzumab), its biosimilar version of Perjeta® (pertuzumab), a biologic medicine used in the treatment of HER2-positive breast cancer.

A common asthma medication improves motor skills and muscle strength in children with congenital myopathies, a group of incurable muscle diseases. In a study, children receiving the drug were able to both walk and stand up more quickly.